Skip to main content
. 2005 May;49(5):2109–2111. doi: 10.1128/AAC.49.5.2109-2111.2005

TABLE 1.

Distribution of T and emm types and macrolide resistance phenotypes among 325 pharyngitis-associated erythromycin-resistant GAS in Portugal during 1998 to 2003

T(emm)a Resultb for yr:
Totalc
1998 1999 2000 2001 2002 2003
12(12) 1/1 0/5 0/4 1/5 0/7 0/2 2 (1)/24
12(22) 42/0 31/0 20/1 15/0 9/0 8/0 125 (113)/1
28(28) 2/0 8/0 7/0 10/0 1/1 28 (2)/1
1(1) 0/3 0/11 0/17 0/4 0/35
25(75) 0/3 0/5 0/3 0/11
4(4) 0/5 0/1 0/6 0/2 0/6 0/12 0/32
12(11) 2/0 2 (2)/0
B3264(4) 0/2 0/2
5/27/44(4) 0/2 0/2
1(12) 0/2 0/2
NT(12)d 0/2 0/4 0/1 0/7
NT(28)d 2/0 2/0
13(22) 3/0 3/0
2(2) 0/2 0/2
2(4) 0/2 0/2
9(9) 0/6 0/1 0/7
Othere 2/0 1/2 1/4 5/4 2/5 1/8 12 (10)/23
Total 45/8 37/10 29/30 30/25 23/41 10/37 174/151
a

All T/emm type combinations presenting ≥2 isolates in any year of the study period are discriminated.

b

Number of isolates presenting each of the erythromycin resistance phenotypes (MLSB/M).

c

Numbers in parenthesis indicate tetracycline-resistant isolates among those presenting the MLSB phenotype. None of the isolates presenting the M phenotype was resistant to tetracycline.

d

NT, nontypeable by T serotyping.

e

Single isolates presenting unique T/emm-type combinations in each year. Most (16/24) of these T/emm combinations were represented by a single isolate during the entire study period. The remaining 8 were represented by more than one isolate each recovered in different years: T13 emm4, T13 emm77, and T12 emm28 were expressed by 3 isolates; T12 emm4, T(B3264) emm89, T1 emm4, T13 emm1, and T(nontypeable) emm1 were expressed by 2 isolates.